Intra-articular Injection of Bone Marrow Aspirate Concentrate (Mesenchymal Stem Cells) in KL Grade III and IV Knee Osteoarthritis: 4-Year Results of 37 Knees
In brief
A prospective study followed patients with severe knee osteoarthritis who received injections of bone marrow aspirate concentrate (BMAC) harvested from the hip bone, over several years. The authors report gradual improvement in knee scores and walking distance, with no patients needing a knee replacement during follow-up; there was no comparison group.
Read the original paper (opens in a new tab)
Citation, as listed in the BMAC guidelines
15. Intra-articular Injection of Bone Marrow Aspirate Concentrate (Mesenchymal Stem Cells) in KL Grade III and IV Knee Osteoarthritis: 4-Year Results of 37 Knees. Scientific Reports (Nature). 2024. https://www.nature.com/articles/s41598-024-51410-2
A summary of published research for general information. It does not replace a consultation; whether a treatment suits you is decided by a specialist after examination.
More from the BMAC guidelines
- Exploring Bias Patterns in Systematic Reviews and Meta-Analyses of Bone Marrow Aspirate Concentrate2026
- Intra-articular Injections for Shoulder Arthritis in Adults: A Systematic Review2025
- Evaluating Clinical Outcomes of Recombinant Human Bone Morphogenetic Protein-2 with ECM and BMAC for Ankle Osteochondral Lesions with Subchondral Damage2025
- Centrifuge-Free Bone Marrow Aspirate Harvest for Orthopaedic Applications2025

